Updates

Plus500

March 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

At Sharewatch we frequently unearth companies that smash forecasts but rarely do we get momentum so powerful as Plus500, which this month released its full year results. As it was, revenues doubled to US$115m and pretax profit went into orbit, rising by 191% to US$67.3m for the year. The margin widened to 58% from 41%. Eps was 44.1 cents. Naturally they have spiked on the news. It is the accelerating Q4 trend that is truly astonishing. Q4 revenues were US$50.4m and ebitda was US$35.8m. That is against Q3's US$29m and US$9.5m, respectively. The number of new customers acquired in Q4 was 19,500 up from 12,700 in Q3. Q4 churn fell to 18% versus 32% and so the number of active customers increased 47% to 85,795 year on year. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Telecom Plus - Record rise in customer numbers

Tungsten - Appoints reseller in Mexico

Plus500 - Exceeds full year forecast in Q1 (June 2020)

Plus500 (March 2020)

Plus500 (July 2014)

Plus500 - Forecasts upgraded-yet again (May 2014)

Plus500 - 66% forecast upgrade (December 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X